annual CFF:
$154.66M+$24.48M(+18.81%)Summary
- As of today (September 15, 2025), TARS annual cash flow from financing activities is $154.66 million, with the most recent change of +$24.48 million (+18.81%) on December 31, 2024.
- During the last 3 years, TARS annual CFF has risen by +$154.63 million (+736357.14%).
- TARS annual CFF is now at all-time high.
Performance
TARS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.95M-$134.61M(-98.57%)Summary
- As of today (September 15, 2025), TARS quarterly cash flow from financing activities is $1.95 million, with the most recent change of -$134.61 million (-98.57%) on June 30, 2025.
- Over the past year, TARS quarterly CFF has dropped by -$40.37 million (-95.39%).
- TARS quarterly CFF is now -98.57% below its all-time high of $136.56 million, reached on March 31, 2025.
Performance
TARS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$142.08M-$40.37M(-22.13%)Summary
- As of today (September 15, 2025), TARS TTM cash flow from financing activities is $142.08 million, with the most recent change of -$40.37 million (-22.13%) on June 30, 2025.
- Over the past year, TARS TTM CFF has dropped by -$133.66 million (-48.47%).
- TARS TTM CFF is now -48.47% below its all-time high of $275.74 million, reached on June 30, 2024.
Performance
TARS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TARS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.8% | -95.4% | -48.5% |
| 3 y3 years | +10000.0% | -97.4% | +51.4% |
| 5 y5 years | +160.2% | - | - |
TARS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -98.6% | +1535.3% | -48.5% | +2414.3% |
| 5 y | 5-year | at high | >+9999.0% | -98.6% | +1535.3% | -48.5% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -98.6% | +1535.3% | -48.5% | >+9999.0% |
TARS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.95M(-98.6%) | $142.08M(-22.1%) |
| Mar 2025 | - | $136.56M(+4565.6%) | $182.45M(+18.0%) |
| Dec 2024 | $154.66M(+18.8%) | $2.93M(+358.1%) | $154.66M(-9.8%) |
| Sep 2024 | - | $639.00K(-98.5%) | $171.49M(-37.8%) |
| Jun 2024 | - | $42.32M(-61.1%) | $275.74M(+17.9%) |
| Mar 2024 | - | $108.77M(+450.5%) | $233.93M(+79.7%) |
| Dec 2023 | $130.18M(+38.5%) | $19.76M(-81.2%) | $130.18M(+17.6%) |
| Sep 2023 | - | $104.89M(>+9900.0%) | $110.68M(+1858.6%) |
| Jun 2023 | - | $510.00K(-89.8%) | $5.65M(-92.9%) |
| Mar 2023 | - | $5.01M(+1798.9%) | $79.88M(-15.0%) |
| Dec 2022 | $93.99M | $264.00K(-294.1%) | $93.99M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$136.00K(-100.2%) | $93.65M(-0.2%) |
| Jun 2022 | - | $74.73M(+290.8%) | $93.86M(+390.7%) |
| Mar 2022 | - | $19.13M(<-9900.0%) | $19.13M(>+9900.0%) |
| Dec 2021 | $21.00K(-100.0%) | -$74.00K(-198.7%) | $21.00K(-100.0%) |
| Sep 2021 | - | $75.00K(+7400.0%) | $91.86M(+0.1%) |
| Jun 2021 | - | $1000.00(-94.7%) | $91.78M(+0.0%) |
| Mar 2021 | - | $19.00K(-100.0%) | $91.78M(+0.1%) |
| Dec 2020 | $131.77M(+121.7%) | $91.76M(<-9900.0%) | $91.74M(<-9900.0%) |
| Mar 2020 | - | -$27.00K | -$27.00K |
| Dec 2019 | $59.45M(+1567.9%) | - | - |
| Dec 2018 | $3.56M | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual CFF year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly CFF year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM CFF year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual cash flow from financing activities?
The current annual CFF of TARS is $154.66M
What is the all time high annual CFF for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual cash flow from financing activities is $154.66M
What is Tarsus Pharmaceuticals, Inc. annual CFF year-on-year change?
Over the past year, TARS annual cash flow from financing activities has changed by +$24.48M (+18.81%)
What is Tarsus Pharmaceuticals, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of TARS is $1.95M
What is the all time high quarterly CFF for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly cash flow from financing activities is $136.56M
What is Tarsus Pharmaceuticals, Inc. quarterly CFF year-on-year change?
Over the past year, TARS quarterly cash flow from financing activities has changed by -$40.37M (-95.39%)
What is Tarsus Pharmaceuticals, Inc. TTM cash flow from financing activities?
The current TTM CFF of TARS is $142.08M
What is the all time high TTM CFF for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM cash flow from financing activities is $275.74M
What is Tarsus Pharmaceuticals, Inc. TTM CFF year-on-year change?
Over the past year, TARS TTM cash flow from financing activities has changed by -$133.66M (-48.47%)